MDxHealth SA ADR is not in a good financial situation at this time. It has a very high odds of going through financial crisis in April. As of now, MDxHealth's Total Current Liabilities is increasing as compared to previous years. The MDxHealth's current Property Plant And Equipment Net is estimated to increase to about 12 M, while Total Stockholder Equity is projected to decrease to under 6.2 M. Key indicators impacting MDxHealth's financial strength include:
The financial analysis of MDxHealth is a critical element in measuring its lifeblood. Investors should not minimize MDxHealth's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
MDxHealth competes with Inozyme Pharma, Day One, Acumen Pharmaceuticals, Eledon Pharmaceuticals, and Elevation Oncology. MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium. Mdxhealth operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 191 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
Comparative valuation techniques use various fundamental indicators to help in determining MDxHealth's current stock value. Our valuation model uses many indicators to compare MDxHealth value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across MDxHealth competition to find correlations between indicators driving MDxHealth's intrinsic value. More Info.
MDxHealth SA ADR is rated below average in return on equity category among its peers. It is considered to be number one stock in return on asset category among its peers . As of now, MDxHealth's Return On Equity is decreasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the MDxHealth's earnings, one of the primary drivers of an investment's value.
MDxHealth SA ADR Systematic Risk
MDxHealth's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. MDxHealth volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on MDxHealth SA ADR correlated with the market. If Beta is less than 0 MDxHealth generally moves in the opposite direction as compared to the market. If MDxHealth Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one MDxHealth SA ADR is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of MDxHealth is generally in the same direction as the market. If Beta > 1 MDxHealth moves generally in the same direction as, but more than the movement of the benchmark.
MDxHealth Thematic Clasifications
MDxHealth SA ADR is part of Healthcare investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Healthcare industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
This theme covers USA Equities from Healthcare industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
Today, most investors in MDxHealth Stock are looking for potential investment opportunities by analyzing not only static indicators but also various MDxHealth's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of MDxHealth growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of MDxHealth help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of MDxHealth SA ADR. We use our internally-developed statistical techniques to arrive at the intrinsic value of MDxHealth SA ADR based on widely used predictive technical indicators. In general, we focus on analyzing MDxHealth Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build MDxHealth's daily price indicators and compare them against related drivers.
When running MDxHealth's price analysis, check to measure MDxHealth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MDxHealth is operating at the current time. Most of MDxHealth's value examination focuses on studying past and present price action to predict the probability of MDxHealth's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MDxHealth's price. Additionally, you may evaluate how the addition of MDxHealth to your portfolios can decrease your overall portfolio volatility.